GFM
CHRS icon

GF Fund Management’s Coherus Oncology CHRS Stock Holding History

GF Fund Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.43K Buy
3,164
+450
+17% +$735 ﹤0.01% 574
2026
Q1 		$4.59K Buy
2,714
+413
+18% +$733 ﹤0.01% 610
2025
Q4 		$3.27K Buy
+2,301
New +$3.35K ﹤0.01% 635

Other funds holding CHRS

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

GF Fund Management's CHRS Position: Q2 2026 in Review

GF Fund Management increased its Coherus Oncology (CHRS) stake by 17% in Q2 2026, buying an estimated $735 and bringing the position to 3,164 shares worth $4.43K. The position accounts for ﹤0.01% of the portfolio, ranked #574.

GF Fund Management first reported a position in CHRS in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.59K in Q1 2026. 147 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.

  • GF Fund Management held 3,164 shares of Coherus Oncology worth $4.43K as of Q2 2026.
  • GF Fund Management bought 450 Coherus Oncology shares in Q2 2026, an estimated $735.
  • Coherus Oncology made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #574 holding.
  • GF Fund Management first reported a position in Coherus Oncology in Q4 2025 and has held it in 3 quarters since.
  • GF Fund Management's Coherus Oncology position peaked at $4.59K in Q1 2026.
  • 147 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.